---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005038"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:43:27.718161+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Royalty Pharma presents at J.P. Morgan; no financial details in filing

## Summary
- Presentation at 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
- Filing references a pending corporate simplification transaction (see Jan 10, 2025 8-K).
- No financial results, guidance, or portfolio updates provided in this exhibit.
- Shareholder vote required for transaction; proxy statement to be filed.

## SEC filing metadata
- accession: 0001193125-25-005038
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312525005038/0001193125-25-005038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312525005038/d919433d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005038
- JSON: https://secwatch.observer/filing/0001193125-25-005038.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.